Bovine Mastitis Drugs & Diagnostics Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global Bovine Mastitis Drugs & Diagnostics market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for Bovine Mastitis Drugs & Diagnostics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Bovine Mastitis Drugs & Diagnostics market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters
Markets Covered: The global bovine mastitis drugs & diagnostics market is segmented by -
Companies Mentioned: Zoetis Inc.; Elanco Animal Health; Boehringer Ingelheim International GmbH; Bayer AG; Merck and Co., Inc.
Countries: Japan, India, Australia, New Zealand, Brazil, Spain, USA, UK, Germany, France, Italy,
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
This product will be delivered within 3-5 business days.
Reasons to Purchase
- Outperform competitors using accurate up to date demand-side dynamics information.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Identify growth segments for investment.
- Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
- Create regional and country strategies on the basis of local data and analysis.
- Stay abreast of the latest customer and market research findings
- Benchmark performance against key competitors.
- Develop strategies based on likely future developments.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest growing market for Bovine Mastitis Drugs & Diagnostics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Bovine Mastitis Drugs & Diagnostics market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters
- Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
- Report Structure - This section gives the structure of the report and the information covered in the various sections.
- Market Characteristics - The market characteristics section of the report defines and explains the bovine mastitis drugs and diagnostics market. This chapter also defines and describes goods and related services covered in the report.
- Trends and Strategies - This chapter describes the major trends shaping the global bovine mastitis drugs and diagnostics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- Impact of COVID-19 - This section describes the impact of COVID-19 on the bovine mastitis drugs and diagnostics market.
- Global Market Size and Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
- Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
- Regional Market Size and Growth - This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
- Competitive Landscape - This section covers details on the competitive landscape of the global bovine mastitis drugs and diagnostics market, estimated market shares and company profiles for the leading players.
- Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
- Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for bovine mastitis drugs and diagnostics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report
Markets Covered: The global bovine mastitis drugs & diagnostics market is segmented by -
- By Product: Antibiotics; Pain Relievers; Surgery; Vaccines; Others
- By Disease: Clinical Mastitis; Sub-clinical Mastitis
- By Type: CMT Kits; PCR Testing; On-Farm Diagnostic Kits; Others
- By End Use: Hospitals and Clinics; Veterinary Centers
Companies Mentioned: Zoetis Inc.; Elanco Animal Health; Boehringer Ingelheim International GmbH; Bayer AG; Merck and Co., Inc.
Countries: Japan, India, Australia, New Zealand, Brazil, Spain, USA, UK, Germany, France, Italy,
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
This product will be delivered within 3-5 business days.
Table of Contents
1. Bovine Mastitis Drugs & Diagnostics Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Bovine Mastitis Drugs & Diagnostics Market Characteristics
7. Bovine Mastitis Drugs & Diagnostics Market Trends and Strategies
8. COVID-19 Impact: Bovine Mastitis Drugs and Diagnostics Market
9. Global Bovine Mastitis Drugs & Diagnostics Market Size and Growth
10. Global Bovine Mastitis Drugs & Diagnostics Market Segmentation
11. Bovine Mastitis Drugs & Diagnostics Market, Regional and Country Analysis
12. Asia-Pacific Bovine Mastitis Drugs & Diagnostics Market
13. Western Europe Bovine Mastitis Drugs & Diagnostics Market
14. Eastern Europe Bovine Mastitis Drugs & Diagnostics Market
15. North America Bovine Mastitis Drugs & Diagnostics Market
16. South America Bovine Mastitis Drugs & Diagnostics Market
17. Middle East Bovine Mastitis Drugs & Diagnostics Market
18. Africa Bovine Mastitis Drugs & Diagnostics Market
19. Global Bovine Mastitis Drugs & Diagnostics Market Competitive Landscape
20. Key Mergers and Acquisitions in The Bovine Mastitis Drugs & Diagnostics Market
21. Bovine Mastitis Drugs & Diagnostics Market Opportunities and Strategies
22. Bovine Mastitis Drugs & Diagnostics Market, Conclusions and Recommendations
23. Appendix
Executive Summary
This report describes and evaluates the global bovine mastitis drugs & diagnostics market. It covers 2015 to 2019, termed the historic period, 2019 through 2023, the forecast period, 2023-2025 forecast period, and 2025-2030 the forecast period.The global bovine mastitis drugs & diagnostics market reached a value of nearly $1,508.7 million in 2019, having increased at a compound annual growth rate (CAGR) of 4.5% since 2015. The market is expected to decline from $1,508.7 million in 2019 to $1,322.5 million in 2020 at a rate of -12.3%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 4.6% from 2021 ad reach $1,864.9 million in 2023 at a CAGR of 5.4%. The market is expected to reach $2,046.0 million by 2025 at a CAGR of 4.7%, and $2,705.0 million by 2030 at a CAGR of 5.7%.
Growth in the historic period resulted from prevalence of bovine mastitis, increased spending on cattle, and rise in milk consumption. Factors that negatively affected growth in the historic period were shortages of veterinarians, and lack of awareness. Going forward, economic growth, increasing public spending, and technological advances will drive the growth. Factors that could hinder the growth of the bovine mastitis drugs & diagnostics market in the future include rising threat of antibiotic resistance, reductions in free trade, and development and use of non-antibiotic based treatment.
The bovine mastitis drugs & diagnostics market is segmented by type into bovine mastitis diagnostics, and bovine mastitis drugs. The bovine mastitis drugs market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by type, accounting for 81.5% of the total in 2019. It is also expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by type, going forward, at a CAGR of 5.5% during 2019-2023.
The bovine mastitis drugs & diagnostics market is also segmented by end use into veterinary centers, hospitals & clinics, and other end use. The veterinary centers market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by end use, accounting for 56.8% of the total in 2019. Going forward, the hospitals & clinics segment is expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by end use, going forward, at a CAGR of 5.5% during 2019-2023.
The bovine mastitis diagnostics market is segmented by type into CMT Kits, on-farm diagnostic kits, PCR testing, and others. The CMT kits market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by type, accounting for 44.8% of the total in 2019. Going forward, the on-farm diagnostic kits segment is expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by type, going forward, at a CAGR of 6.2% during 2019-2023.
The bovine mastitis drugs market is segmented by product into antibiotics, pain relievers, vaccines, surgery, and other product. The antibiotics market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by product, accounting for 43.2% of the total in 2019. Going forward, the pain relievers segment is expected to be the fastest growing segment in the bovine mastitis drugs & diagnostics market segmented by product, going forward, at a CAGR of 6.7% during 2019-2023.
The bovine mastitis drugs market is also segmented by disease into sub-clinical mastitis, and clinical mastitis. The sub-clinical mastitis market was the largest segment of the bovine mastitis drugs & diagnostics market segmented by disease, accounting for 60.3% of the total in 2019. It is also expected to be the fastest growing segment in the bovine mastitis drugs market segmented by disease, going forward, at a CAGR of 5.8% during 2019-2023.
North America was the largest region in the global bovine mastitis drugs & diagnostics market, accounting for 43.8% of the total in 2019. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the bovine mastitis drugs & diagnostics market will be North America, and Asia Pacific, where growth will be at CAGRs of 6.7% and 5.9% respectively. These will be followed by Africa, and the Middle East, where the markets are expected to grow at CAGRs of 5.1% and 3.9% respectively.
The global bovine mastitis drugs & diagnostics market is concentrated, with a small number of large players the market. The top ten competitors in the market made up to 59.4% of the total market in 2019. Major players in the market include Zoetis Inc., Bayer AG, Elanco Animal Health, Merck and Co., Boehringer Ingelheim GmbH.
The top opportunities in the bovine mastitis drugs & diagnostics market segmented by type will arise in the Bovine Mastitis Drugs segment, which will gain $293.5 million of global annual sales by 2023. The top opportunities in the bovine mastitis drugs & diagnostics market segmented by end use will arise in the veterinary centers segment, which will gain $202.2 million of global annual sales by 2023. The top opportunities in the bovine mastitis diagnostics market segmented by product type will arise in the CTM kits segment, which will gain $25.7 million of global annual sales by 2023. The top opportunities in the bovine mastitis drugs market segmented by product will arise in the antibiotics segment, which will gain $110.7 million of global annual sales by 2023. The top opportunities in the bovine mastitis drugs market segmented by disease will arise in the sub-clinical mastitis segment, which will gain $189.3 million of global annual sales by 2023.
Market-trend-based strategies for the bovine mastitis drugs & diagnostics market include investing in the developing nanoparticles as substitutes of conventional drugs, focusing on the research and development of innovative mastitis diagnostic kits, focusing on the development of innovative biosensors to improve bovine mastitis diagnosis, focusing on the development of non-antibiotic therapy, and integrating machine learning. Player-adopted strategies in the bovine mastitis drugs & diagnostics market include expanding through new drugs, expanding through acquisitions, and expanding through strategic collaborations.
The COVID-19 pandemic has decreased short-term potential growth opportunities for the bovine mastitis drugs & diagnostics industry.
To take advantage of the opportunities, the publisher recommends bovine mastitis drugs & diagnostics market companies to invest in nanotechnology, invest in biosensors for bovine mastitis diagnosis, focus on development of non-antibiotic treatment, invest in machine learning, expand in emerging markets, provide competitively priced offerings, participate in veterinary conferences and events and collaborate with veterinarians.
Companies Mentioned
- Zoetis Inc.
- Elanco Animal Health
- Boehringer Ingelheim International GmbH
- Bayer AG
- Merck and Co., Inc.
Methodology
LOADING...
